Retifanlimab Plus Carboplatin and Paclitaxel Offers PFS Benefit in Recurrent/Metastatic SCAC
Addition of Radium-223 to Enzalutamide Significantly Improves rPFS and OS in mCRPC
Zipalertinib Demonstrates Safety, Disease Control in Heavily Pretreated EGFR Exon 20-Mutated NSCLC
Relatlimab Plus Nivolumab and Chemo Improves Clinical Benefit in Stage IV NSCLC